PAM2L Biotechnologies

Shenzhen, China · Founded 2021 · Privately Held (backing)

Developer of biomaterial innovation and application intended for the synthetic biology sector. PAM2L Biotechnologies is based in Shenzhen, China and was founded in 2021. Its last reported valuation was $88.8 million in Jan 2023. It has raised $19.1 million.

Last reported valuation
$88.8M
Oct 2026
Priced at
—
Total raised
$19.1M
Last round
—

Who backs PAM2L Biotechnologies?

11 investors
InvestorType
Co-Stone CapitalPE / buyout
5Y CapitalOther
Yunqi PartnersVenture capital
Shenzhen Angel Investment Guiding FundOther
Guangzhou Guangyao CapitalPE / buyout
GRC SinoGreen Fund—
Lighthouse Capital (China)—
Sinvo Capital—
Skyrise.Tech—
Tiantu Capital—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PAM2L Biotechnologies investors

11 investors are on record for PAM2L Biotechnologies, including Co-Stone Capital, 5Y Capital, Yunqi Partners and Shenzhen Angel Investment Guiding Fund.

Free account
More of PAM2L Biotechnologies with a free account
  • ·The complete investor list: 11 names
  • ·Watch PAM2L Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like PAM2L Biotechnologies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View